AnalysisIndia Research Team

Top pharmaceutical companies driving innovation in 2025 through artificial intelligence, precision medicine, digital health, and advanced therapies.

Top Pharmaceutical Companies Driving Innovation in 2025

Pharmaceutical, Healthcare Market Analysis / /

Analysis India: The global healthcare landscape is changing rapidly, and the pharmaceutical sector is at the center of this transformation. In 2025, innovation is no longer limited to drug discovery alone. It now includes digital health, artificial intelligence, sustainability, and patient centric care models. The top pharmaceutical companies driving innovation in 2025 are shaping the […]

Top Pharmaceutical Companies Driving Innovation in 2025 Read More »

Price increases on hundreds of drugs in United States in 2026 showing rising prescription drug costs

Price Increases on Hundreds of Drugs in United States

Pharmaceutical, Healthcare Market Analysis / /

Introduction Price increases on hundreds of drugs in United States have emerged as one of the most important healthcare developments in 2026. As the new year begins pharmaceutical companies are once again adjusting prices across a wide range of prescription medicines. These changes are happening despite continued political pressure to improve affordability and reduce the

Price Increases on Hundreds of Drugs in United States Read More »

US drug pricing trends 2026 showing Pfizer drug price strategy impact

US Drug Pricing Trends 2026 Pfizer’s Strategy Reflects Broader Industry Shift

Pharmaceutical, Company News / /

Introduction US drug pricing trends 2026 are shaping up to be one of the most closely watched healthcare developments this year. As pharmaceutical companies begin the new pricing cycle many have moved forward with price revisions even as political pressure around affordability continues to grow. For patients healthcare providers and insurers these decisions have immediate

US Drug Pricing Trends 2026 Pfizer’s Strategy Reflects Broader Industry Shift Read More »

Semaglutide patent expiry creating new growth opportunity for generic drug makers and Indian pharma companies

Semaglutide Patent Expiry and the Emerging Generics Opportunity Globally

Pharmaceutical, Healthcare Market Analysis / /

The semaglutide patent expiry is becoming one of the most discussed developments in the global pharmaceutical industry. It marks a structural shift in the diabetes and obesity treatment market. For years semaglutide based therapies have remained under strong patent protection which allowed premium pricing and limited competition. As patent protection gradually weakens the market is

Semaglutide Patent Expiry and the Emerging Generics Opportunity Globally Read More »

Heal in India initiative highlighting India medical tourism 2025 and affordable world class healthcare

India’s Medical Tourism Growth: What Global Patients Need to Know

Travel & Tourism Market Analysis, Industry Insights / /

Analysis India: India medical tourism 2025 reflects a major shift in how international patients access healthcare and wellness services. What was once a small and specialised segment has now become a significant driver of healthcare access, wellness travel, and economic development across the country. Patients from across the world are increasingly choosing India for advanced

India’s Medical Tourism Growth: What Global Patients Need to Know Read More »

Subscribe
Subscribe
×